NCT02192853View on ClinicalTrials.gov

Correlation Between Plasma- and Endothelial DPP-4 Activity

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

March 31, 2014

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

sitagliptin

"In randomized order:~Day 1: tablet of 25 mg of sitagliptin + i.v. GLP-1 infusion Day 2: tablet of 100 mg of sitagliptin + i.v. GLP-1 infusion Day 3: tablet of 200 mg of sitagliptin + i.v. GLP-1 infusion"

DRUG

Placebo

Day 4: placebo tablet

Trial Locations (1)

2900

Diabetes Research Division, Department of Endocrinology, Gentofte Hospital, Hellerup

All Listed Sponsors
lead

University Hospital, Gentofte, Copenhagen

OTHER

NCT02192853 - Correlation Between Plasma- and Endothelial DPP-4 Activity | Biotech Hunter | Biotech Hunter